evidencegaps
Primary study · included by 1 review

miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients.

Piotrowski 2021 · Piotrowski Igor, Zhu Xiang, Saccon Tatiana Dandolini, et al. · Cancers · 2021

Included by

Prognostic Impact of miR-34a in Head and Neck Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Non-Cochrane · prognostic · 2026 · cited as Piotrowski 2021 · Table 1; Table 2; References
Outcome this study informsPooled effectEvidenceCertainty
Overall survival
Low tumor-tissue miR-34a expression (study-defined cut-off) vs High tumor-tissue miR-34a expression
HR 2.25 [1.48, 3.41]2 studies · 225 participantsLow
Overall survival
Low tumor-tissue miR-34a expression (study-defined cut-off) vs High tumor-tissue miR-34a expression
HR 1.32 [0.32, 5.54]2 studies · 225 participantsLow

1 including review in total.